title: [Are there guidelines for timing readministration of anticoagulation with marcumar in patients with artificial heart valves after intracerebral hemorrhage (stroke, subarachnoid hemorrhage, subdural hematoma)?].
authors.affiliation: Medizinische Klinik und Poliklinik, Abteilung Innere Medizin A, Münster.
authors.forename: J
authors.initials: J
authors.lastname: Kienast
authors.forename: E B
authors.initials: EB
authors.lastname: Ringelstein
authors.forename: M
authors.initials: M
authors.lastname: Borggrefe
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D001780:Blood Coagulation Tests; D002543:Cerebral Hemorrhage / Q000097:blood / Q000139:chemically induced*; D006350:Heart Valve Prosthesis; D006801:Humans; D010644:Phenprocoumon / Q000008:administration & dosage / Q000009:adverse effects*; D011183:Postoperative Complications / Q000097:blood / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D010644:Phenprocoumon